Modifications  ||| S:0 E:14 ||| NNS
of  ||| S:14 E:17 ||| IN
the  ||| S:17 E:21 ||| DT
marginal  ||| S:21 E:30 ||| JJ
paradentium  ||| S:30 E:42 ||| NN
to  ||| S:42 E:45 ||| TO
a  ||| S:45 E:47 ||| DT
case  ||| S:47 E:52 ||| NN
of  ||| S:52 E:55 ||| IN
Angle  ||| S:55 E:61 ||| NNP
Class  ||| S:61 E:67 ||| NNP
III ||| S:67 E:70 ||| NNP
/ ||| S:70 E:71 ||| CD
1  ||| S:71 E:73 ||| CD
malocclusion  ||| S:73 E:86 ||| JJ
Angle  ||| S:86 E:92 ||| NNP
Class  ||| S:92 E:98 ||| NNP
III  ||| S:98 E:102 ||| NNP
malocclusions  ||| S:102 E:116 ||| NNS
are  ||| S:116 E:120 ||| VBP
not  ||| S:120 E:124 ||| RB
so  ||| S:124 E:127 ||| RB
frequently  ||| S:127 E:138 ||| RB
met  ||| S:138 E:142 ||| VBN
but  ||| S:142 E:146 ||| CC
they  ||| S:146 E:151 ||| PRP
raise  ||| S:151 E:157 ||| VBP
big  ||| S:157 E:161 ||| JJ
problems  ||| S:161 E:170 ||| NNS
of  ||| S:170 E:173 ||| IN
treatment ||| S:173 E:182 ||| NN
.  ||| S:182 E:184 ||| .
The  ||| S:184 E:188 ||| DT
analyzed  ||| S:188 E:197 ||| JJ
case  ||| S:197 E:202 ||| NN
represents  ||| S:202 E:213 ||| VBZ
a  ||| S:213 E:215 ||| DT
14-year-old  ||| S:215 E:227 ||| JJ
patient  ||| S:227 E:235 ||| NN
that  ||| S:235 E:240 ||| WDT
came  ||| S:240 E:245 ||| VBD
to  ||| S:245 E:248 ||| TO
the  ||| S:248 E:252 ||| DT
dental  ||| S:252 E:259 ||| JJ
consulting  ||| S:259 E:270 ||| NN
room  ||| S:270 E:275 ||| NN
with  ||| S:275 E:280 ||| IN
an  ||| S:280 E:283 ||| DT
Angle  ||| S:283 E:289 ||| NNP
Class  ||| S:289 E:295 ||| NNP
III  ||| S:295 E:299 ||| NNP
malocclusion  ||| S:299 E:312 ||| VBD
determined  ||| S:312 E:323 ||| VBN
by  ||| S:323 E:326 ||| IN
the  ||| S:326 E:330 ||| DT
excess  ||| S:330 E:337 ||| NN
of  ||| S:337 E:340 ||| IN
the  ||| S:340 E:344 ||| DT
somatotropic  ||| S:344 E:357 ||| JJ
pituitary  ||| S:357 E:367 ||| JJ
hormone  ||| S:367 E:375 ||| NN
and  ||| S:375 E:379 ||| CC
a  ||| S:379 E:381 ||| DT
gingival  ||| S:381 E:390 ||| JJ
hyperplasia  ||| S:390 E:402 ||| NN
more  ||| S:402 E:407 ||| RBR
emphasized  ||| S:407 E:418 ||| VBN
at  ||| S:418 E:421 ||| IN
the  ||| S:421 E:425 ||| DT
level  ||| S:425 E:431 ||| NN
of  ||| S:431 E:434 ||| IN
inferior  ||| S:434 E:443 ||| JJ
frontal  ||| S:443 E:451 ||| JJ
teeth ||| S:451 E:456 ||| NNS
.  ||| S:456 E:458 ||| .
The  ||| S:458 E:462 ||| DT
patient  ||| S:462 E:470 ||| NN
followed  ||| S:470 E:479 ||| VBD
a  ||| S:479 E:481 ||| DT
fixed  ||| S:481 E:487 ||| JJ
appliance  ||| S:487 E:497 ||| NN
treatment ||| S:497 E:506 ||| NN
,  ||| S:506 E:508 ||| ,
the  ||| S:508 E:512 ||| DT
straight-wire  ||| S:512 E:526 ||| JJ
technique ||| S:526 E:535 ||| NN
.  ||| S:535 E:537 ||| .
All  ||| S:537 E:541 ||| DT
along  ||| S:541 E:547 ||| IN
the  ||| S:547 E:551 ||| DT
treatment  ||| S:551 E:561 ||| NN
and  ||| S:561 E:565 ||| CC
after  ||| S:565 E:571 ||| IN
it ||| S:571 E:573 ||| PRP
,  ||| S:573 E:575 ||| ,
the  ||| S:575 E:579 ||| DT
hyperplasia  ||| S:579 E:591 ||| NN
and  ||| S:591 E:595 ||| CC
the  ||| S:595 E:599 ||| DT
gingival  ||| S:599 E:608 ||| JJ
inflammation  ||| S:608 E:621 ||| NNS
not  ||| S:621 E:625 ||| RB
only  ||| S:625 E:630 ||| RB
maintained  ||| S:630 E:641 ||| VBN
but  ||| S:641 E:645 ||| CC
they  ||| S:645 E:650 ||| PRP
even  ||| S:650 E:655 ||| RB
got  ||| S:655 E:659 ||| VBD
worse ||| S:659 E:664 ||| JJR
.  ||| S:664 E:666 ||| .
Thus ||| S:666 E:670 ||| RB
,  ||| S:670 E:672 ||| ,
an  ||| S:672 E:675 ||| DT
improper  ||| S:675 E:684 ||| JJ
hygiene  ||| S:684 E:692 ||| NNS
associated  ||| S:692 E:703 ||| VBN
with  ||| S:703 E:708 ||| IN
a  ||| S:708 E:710 ||| DT
severe  ||| S:710 E:717 ||| JJ
Angle  ||| S:717 E:723 ||| NNP
Class  ||| S:723 E:729 ||| NNP
III  ||| S:729 E:733 ||| NNP
malocclusion  ||| S:733 E:746 ||| NN
maintains  ||| S:746 E:756 ||| VBZ
and  ||| S:756 E:760 ||| CC
aggravates  ||| S:760 E:771 ||| VBZ
the  ||| S:771 E:775 ||| DT
gingivitis ||| S:775 E:785 ||| NN
.  ||| S:785 E:787 ||| .
The  ||| S:787 E:791 ||| DT
histological  ||| S:791 E:804 ||| NN
and  ||| S:804 E:808 ||| CC
immunohistochemical  ||| S:808 E:828 ||| JJ
study  ||| S:828 E:834 ||| NN
of  ||| S:834 E:837 ||| IN
the  ||| S:837 E:841 ||| DT
gingiva  ||| S:841 E:849 ||| NN
revealed  ||| S:849 E:858 ||| VBD
important  ||| S:858 E:868 ||| JJ
epithelial  ||| S:868 E:879 ||| JJ
modifications  ||| S:879 E:893 ||| NNS
that  ||| S:893 E:898 ||| WDT
led  ||| S:898 E:902 ||| VBD
to  ||| S:902 E:905 ||| TO
an  ||| S:905 E:908 ||| DT
epithelial  ||| S:908 E:919 ||| JJ
hypertrophy  ||| S:919 E:931 ||| NN
with  ||| S:931 E:936 ||| IN
a  ||| S:936 E:938 ||| DT
tendency  ||| S:938 E:947 ||| NN
toward  ||| S:947 E:954 ||| IN
acanthosis  ||| S:954 E:965 ||| NN
and  ||| S:965 E:969 ||| CC
to  ||| S:969 E:972 ||| TO
severe  ||| S:972 E:979 ||| JJ
epithelial  ||| S:979 E:990 ||| JJ
erosions ||| S:990 E:998 ||| NN
.  ||| S:998 E:1000 ||| .
An  ||| S:1000 E:1003 ||| DT
inflammatory  ||| S:1003 E:1016 ||| JJ
chronic  ||| S:1016 E:1024 ||| JJ
process  ||| S:1024 E:1032 ||| NN
( ||| S:1032 E:1033 ||| -LRB-
rich  ||| S:1033 E:1038 ||| JJ
in  ||| S:1038 E:1041 ||| IN
lymphocytes ||| S:1041 E:1052 ||| NN
,  ||| S:1052 E:1054 ||| ,
plasma  ||| S:1054 E:1061 ||| JJ
cells  ||| S:1061 E:1067 ||| NNS
and  ||| S:1067 E:1071 ||| CC
macrophages  ||| S:1071 E:1083 ||| JJ
full  ||| S:1083 E:1088 ||| JJ
of  ||| S:1088 E:1091 ||| IN
angiogenesis  ||| S:1091 E:1104 ||| JJ
vessels ||| S:1104 E:1111 ||| NNS
)  ||| S:1111 E:1113 ||| -RRB-
and  ||| S:1113 E:1117 ||| CC
an  ||| S:1117 E:1120 ||| DT
intense  ||| S:1120 E:1128 ||| JJ
reaction  ||| S:1128 E:1137 ||| NN
of  ||| S:1137 E:1140 ||| IN
the  ||| S:1140 E:1144 ||| DT
fibroblastic  ||| S:1144 E:1157 ||| JJ
cells  ||| S:1157 E:1163 ||| NNS
appeared  ||| S:1163 E:1172 ||| VBD
in  ||| S:1172 E:1175 ||| IN
the  ||| S:1175 E:1179 ||| DT
gingival  ||| S:1179 E:1188 ||| JJ
corium ||| S:1188 E:1194 ||| NN
.  ||| S:1194 E:1196 ||| .
